Vitamin E as a Treatment for Nonalcoholic Fatty Liver Disease: Reality or Myth?
Obesity is one of the major epidemics of this millennium, and its incidence is growing worldwide. Following the epidemics of obesity, nonalcoholic fatty liver disease (NAFLD) has become a disease of increasing prevalence and a leading cause of morbidity and mortality closely related to cardiovascula...
Main Authors: | Hamza El Hadi, Roberto Vettor, Marco Rossato |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-01-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-3921/7/1/12 |
Similar Items
-
Obesity and nonalcoholic fatty liver disease: metabolic risks and their correction
by: Kseniya Andreevna Komshilova, et al.
Published: (2015-08-01) -
Comparison between obese and non-obese nonalcoholic fatty liver disease
by: Wah-Kheong Chan
Published: (2023-02-01) -
Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
by: Ekaterina E. Mishina, et al.
Published: (2017-12-01) -
Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
by: Ho Soo Chun, et al.
Published: (2023-04-01) -
Nonalcoholic fatty liver disease and non-liver comorbidities
by: Richie Manikat, et al.
Published: (2023-02-01)